Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
1.935 USD | -0.77% | -1.56% | -17.06% |
May. 09 | Transcript : Xeris Biopharma Holdings, Inc., Q1 2024 Earnings Call, May 09, 2024 | |
May. 09 | Earnings Flash (XERS) XERIS BIOPHARMA HOLDINGS Reports Q1 Revenue $40.6M, vs. Street Est of $41.8M | MT |
Financials (USD)
Sales 2024 * | 185M | Sales 2025 * | 219M | Capitalization | 289M |
---|---|---|---|---|---|
Net income 2024 * | -60M | Net income 2025 * | -30M | EV / Sales 2024 * | 1.57 x |
Net cash position 2024 * | - | Net cash position 2025 * | - | EV / Sales 2025 * | 1.32 x |
P/E ratio 2024 * |
-4.62
x | P/E ratio 2025 * |
-9.29
x | Employees | 377 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 97.09% |
Latest transcript on Xeris Biopharma Holdings, Inc.
1 day | -2.99% | ||
1 week | -3.47% | ||
Current month | +11.43% | ||
1 month | +9.55% | ||
3 months | -35.22% | ||
6 months | +12.07% | ||
Current year | -17.02% |
Managers | Title | Age | Since |
---|---|---|---|
Paul Edick
CEO | Chief Executive Officer | 67 | 21-04-30 |
Steven Pieper
DFI | Director of Finance/CFO | 47 | 21-09-30 |
John Shannon
PSD | President | 62 | 21-10-04 |
Members of the board | Title | Age | Since |
---|---|---|---|
John Johnson
BRD | Director/Board Member | 66 | 21-10-04 |
Jeffrey Sherman
BRD | Director/Board Member | 69 | 21-10-04 |
Marla Persky
BRD | Director/Board Member | 68 | 21-10-04 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
0.00% | 9 M€ | +9.29% | - |
Date | Price | Change | Volume |
---|---|---|---|
24-05-24 | 1.945 | -0.26% | 210 558 |
24-05-23 | 1.95 | -2.99% | 911,564 |
24-05-22 | 2.01 | +0.50% | 624,076 |
24-05-21 | 2 | -2.44% | 852,214 |
24-05-20 | 2.05 | +3.54% | 779,770 |
Delayed Quote Nasdaq, May 23, 2024 at 04:00 pm EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-17.02% | 289M | |
+38.69% | 728B | |
+33.29% | 603B | |
-4.49% | 360B | |
+20.24% | 332B | |
+2.12% | 279B | |
+15.72% | 244B | |
+7.61% | 207B | |
-5.40% | 205B | |
-0.35% | 163B |
- Stock Market
- Equities
- XERS Stock